A lower, 100 mg dose of Nucala (mepolizumab) is equally effective at treating eosinophilic granulomatosis with polyangiitis (EGPA)…
Articles by Steve Bryson, PhD
ChemoCentryx has filed an amendment to its application seeking approval of avacopan, an investigational therapy for the treatment…
Using lower doses of prednisolone in combination with Rituxan (rituximab) resulted in similar rates of remission and fewer…
The likelihood of developing ANCA-associated vasculitis rises significantly among people living near quarries…
A committee of the U.S. Food and Drug Administration (FDA) — which provides the agency with non-binding recommendations…
Serious infections occur more frequently in people with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis who…
Vasculitis UK has granted £53,364 (about $73,500) to support a research project investigating how people…
Changes in autoantibodies that target the protein PR3 in people with ANCA-associated vasculitis…
A group of proteins that modulate immune responses, called heat shock proteins (HSPs), are significantly elevated in…
Low levels of the protein alpha-1-antitrypsin (AAT) do not appear to be enough to increase the risk…